33. Knu ̈ sel B., Winslow J. W., Rosenthal A., Burton L. E., Seid D. P., Nikolics K. and Hefti F. (1991) Promotion of
central cholinergic and dopaminergic neuron diVerentiation by BDNF but not NT-3. Proc. natn. Acad. Sci. U.S.A. 88,
961–965.
34. Knu ̈ sel B., Beck K. D., Winslow J. W., Rosenthal A., Burton L. E., Widmer H. R., Nikolics K. and Hefti F. (1992)
Brain-derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic
neurons from degenerative changes after axotomy in the adult rat brain. J. Neurosci. 12, 4391–4402.
35. Korsching S. (1993) The neurotrophic factor concept: a reexamination. J. Neurosci. 13, 2739–2748.
36. Lapchak P. A., Beck K. D., Araujo D. M., Irwin I., Langston J. W. and Hefti F. (1993) Chronic intranigral
administration of BDNF produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection. Neuroscience 53,
639–650.
37. Leibrock J., Lottspeich F., Hohn A., Hofer M., Hengerer B., Masiakowski P., Thoenen H. and Barde Y. A. (1989)
Molecular cloning and expression of brain-derived neurotrophic factor. Nature 341, 149–152.
38. Levi-Montalcini R. (1987) The nerve growth factor 35 years later. Science 237, 1154–1562.
39. Levivier M., Przedborski S., Bencsics C. and Kang U. J. (1995) Intrastriatal implantation of fibroblasts genetically
engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat
model of Parkinson's disease. J. Neurosci. 15, 7810–7820.
40. Lindvall O., Kokaia Z., Bengzon J., Elmer E. and Kokaia Z. (1994) Neurotrophins and brain insults. Trends Neurosci.
17, 490–496.
41. Maisonpierre P. C., Belluscio L., Squinto S., Ip N. Y., Furth M. E., Lindsay R. M. and Yancopoulos G. D. (1990)
Neurotrophin-3: a neurotrophic factor related to NGF and BDNF. Science 247, 1446–1451.
42. Martin-Zanca D., Oskam R., Mitra G., Copeland T. and Barbacid M. (1989) Molecular and biochemical
characterization of the human trk protooncogene. Molec. cell. Biol. 9, 24–33.
43. Meakin S. O. and Shooter E. M. (1993) The nerve growth factor family of receptors. Trends Neurosci. 15, 323–331.
44. Merlio J. P., Ernfors P., Jaber M. and Persson H. (1992) Molecular cloning of rat TrkC and distribution of
cells expressing messenger RNAs for members of the Trk family in the rat central nervous system. Neuroscience 51,
513–532.
45. Middlemass D. S., Lindberg R. A. and Hunter T. (1991) TrkB, a neural receptor protein kinase: evidence for a
full-length and two truncated receptors. Molec. cell. Biol. 11, 143–153.
46. Mufson E. J., Kroin J. S., Liu Y. T., Sobreviela R., Penn R. D., Miller J. A. and Kordower J. H. (1996) Intrastriatal
and intraventricular infusion of brain-derived neurotrophic factor in the cynologous monkey: distribution, retrograde
transport and co-localization with substantia nigra dopamine containing neurons. Neuroscience 71, 179–191.
47. Onn S., Berger T. W., Stricker E. M. and Zigmond M. J. (1986) EVects of intraventricular 6-hydroxydopamine on the
dopaminergic innervation of striatum: histochemical and neurochemical analysis. Brain Res. 376, 8–19.
48. Rosenthal A., Goeddel D. V., NGuyen T., Lewis M., Shih A., Laramee G. R., Nikolics K. and Winslow J. W. (1990)
Primary structure and biological activity of a novel neurotrophic factor. Neuron 4, 767–773.
49. Schmidt-Kastner R., Wetmore C. and Olson L. (1996) Comparative study of BDNF messenger RNA and protein at
the cellular level suggests multiple roles in the hippocampus, striatum and cortex. Neuroscience 74, 161–183.
50. Segal R. A., Pomeroy S. L. and Stiles C. D. (1995) Axonal growth and fasciculation linked to diVerential expression
of BDNF and NT-3 receptors in developing cerebellar granule cells. J. Neurosci. 15, 4970–4981.
51. Seroogy K. B. and Gall C. M. (1993) Expression of neurotrophins by midbrain dopaminergic neurons. Expl Neurol.
124, 119–128.
52. Shelton D. L., Sutherland J., Gripp J., Camerato T., Armanini M. P., Phillips H. S., Carroll K., Spencer S. D. and
Levinson A. D. (1995) Human Trks: molecular cloning, tissue distribution, and expression of extracellular domain
immunoadhesins. J. Neurosci. 15, 477–491.
53. Soppet D., Escandon E., Maragos J., Kaplan D. R., Hunter T., Nikolics M. and Parada L. F. (1991) The neurotrophic
factors BDNF and NT-3 are ligands for the TrkB tyrosine kinase receptor. Cell 65, 895–903.
54. Spina M. B., Squinto S. P., Miller J., Lindsay R. M. and Hyman C. (1992) BDNF protects dopamine neurons against
6-OHDA and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathion system. J. Neurochem. 59,
99–106.
55. Squinto S. P., Stitt T. N., Aldrich T. H., Davis S., Bianco S. M., Radziejewski C., Glass D. J., Masiakowski P., Furth
M. E., Valuenzela D. M., DiStefano P. S. and Yancopoulos G. D. (1991) TrkB encodes a functional receptor for
BDNF and NT-3 but not NGF. Cell 65, 885–893.
56. Timmusk T., Belluardo N., Metsis M. and Persson H. (1993) Widespread and developmentally regulated expression
of neurotrophin-4 in rat brain and peripheral tissues. Eur. J. Neurosci. 5, 605–613.
57. Wetmore C., Ernfors P., Persson H. and Olson L. (1990) Localization of BDNF mRNA to neurons in the brain by
in situ hybridization. Expl Neurol. 109, 141–152.
58. Yan Q., Radeke M. J., Matheson C., Talvenheimo J., Welcher A. A. and Feinstein S. C. (1997) Immunocytochemical
localization of TrkB in the central nervous system of the adult rat. J. comp. Neurol. 378, 135–157.
